Data released by the Irish Health Department in the 2021 "Healthy Ireland" survey shows that smoking rates have increased from 17% to 18% in the past two years. The Irish Vaping Business (VBI) has commented on this, attributing the rise in smoking rates to the continued refusal to use verified harm-reducing products such as e-cigarettes and stating that this is the first-hand evidence that the 2025 goal of achieving a smoke-free Ireland is failing.
Eoin O'Boyle, spokesperson for VBI, has said that these findings are in stark contrast to the UK, where tobacco harm reduction (THR) has been fully embraced. "Today's results are a major blow to the ambitious goal of establishing a smoke-free society by 2025. A contributing factor to potentially missing this target is our public health institutions' continued disregard for proven harm reduction options, such as electronic cigarettes. This stands in stark contrast to the UK, where smoking rates have been declining for a long time, a trend that has been aided by the adoption of electronic cigarettes as a less harmful alternative.
Although last year's statistic of 44% of smokers attempting to quit is encouraging, only a quarter of those attempts were successful. This brings into question whether those trying to quit are receiving enough support and information. According to O'Boyle, providing public information on reduced-risk products, including e-cigarettes, by health institutions would greatly increase the success rate of quitting smoking.
Health Ireland Survey 2021
VBI has released a summary of the results of the 2021 Healthy Ireland Survey for Ireland as follows:
Currently, 4% of the population uses electronic cigarette products, representing a 1% decrease from the 2019 figure.
Six percent of the population who smoke and three percent of non-smokers use electronic cigarettes.
Among non-smokers, 10% of former smokers use e-cigarette products, while less than 1% of never-smokers use e-cigarette products.
Over the past 12 months, 18% of individuals attempting to quit smoking have tried using e-cigarettes as a method.
Tobacco prices
Earlier this year, Ireland announced an increase in cigarette prices as part of their 2022 plan. The Wall Street Journal emphasized that taxes on a packet of 20 cigarettes have risen for the sixth year in a row and now stand at a staggering €15 per pack.
The Irish Minister for Finance, Paschal Donohoe, has stated that the recent increase in cigarette prices is aimed at deterring smoking and supporting local public health policy goals. However, the Irish Heart Foundation believes that the increase is not enough to address the issue of young people smoking. The organization had previously recommended an increase to €20 by 2025, with a €2 increase this year, and supports the current imposition of a consumption tax on e-cigarette products.
Tobacco and Nicotine Legislation
Meanwhile, the recent Public Health (Tobacco and Nicotine Inhaling Products) Bill proposes a ban on the sale of tobacco products in temporary venues and children’s activity areas, along with prohibiting those under 18 from purchasing tobacco or nicotine inhaling products. In discussions surrounding the ban, Siobhain Brophy, of the Tobacco and Alcohol Control, told the Oireachtas Health Committee that banning e-cigarettes would have a negative impact since 38% of those attempting to quit smoking use them.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
